Plasma vitamin D and cytokines in periodontal disease and postmenopausal osteoporosis

Journal of Periodontal Research

Volumn 46, Issue 1, 2011, Pages 97-104

  Jabbar, S ^a   Drury, J ^a   Fordham, J ^a   Datta, H K ^b   Francis, R M ^b   Tuck, S P ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cytokine; Osteoporosis; Periodontal disease; Vitamin D

Indexed keywords

CALCIFEDIOL; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; CYTOKINE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PEPTIDE;

AGED; ARTICLE; BLOOD; BONE DENSITY; BONE REMODELING; CASE CONTROL STUDY; CHEMISTRY; FEMALE; HUMAN; LUMBAR VERTEBRA; MIDDLE AGED; PERIODONTAL DISEASE; POSTMENOPAUSE OSTEOPOROSIS; QUESTIONNAIRE; STATISTICAL MODEL;

AGED; BONE DENSITY; BONE REMODELING; CALCIFEDIOL; CASE-CONTROL STUDIES; COLLAGEN TYPE I; CYTOKINES; FEMALE; HUMANS; LOGISTIC MODELS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPROTEGERIN; PEPTIDES; PERIODONTAL DISEASES; QUESTIONNAIRES; RANK LIGAND;

EID: 78650899896     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2010.01317.x     Document Type: Article

References (81)

1. Löe H. Oral hygiene in the prevention of caries and periodontal disease. Int Dent J 2000;50:129-139.
2. Takemura A, Nishida M. Application of dietary supplements to periodontal disease and osteoporosis. Clin Calcium 2006;16: 354-358.
3. Reddy MS. Oral osteoporosis: is there an association between periodontal diseases and osteoporosis? Comp Cont Educ Dent 2002;10(Suppl):21-28.
4. Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. J Periodontol 2001;72:779-787.
5. Desvarieux M. Periodontal disease, race, and vascular disease. Comp Cont Educ Dent 2001;22:34-41.
6. Krejci CB. Women's health issues and their relationship to periodontitis. J Am Dent Assoc 2002;133:323-329.
7. Mercado FB, Marshall RI, Bartold PM. Inter-relationships between rheumatoid arthritis and periodontal disease. J Clin Periodontol 2003;30:761-772.
8. Okamoto Y, Ttsuboi S, Suzuki S et al. Effects of smoking and drinking habits on the incidence of periodontal disease and tooth loss among Japanese males. J Periodontal Res 2006;41:560-566.
9. Thomson WM, Poulton R, Broadbent JM, Moffitt TE, Caspi A, Beck JD. Cannabis smoking and periodontal disease among young adults. JAMA 2008;299: 525-531.
10. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000;15:2-12.
11. Roger A, Eastell R. Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 2005;90:6323-6331.
12. Metzler I, Krebbel H, Kuckelhorne U et al. Curcumin diminishes human osteoclastogenesis by inhibition of the signalosome-associated IκB kinase. J Cancer Res Clin 2008;135:173-179.
13. Valverde P. Over expression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice. J Bone Miner Res 2008;23:1775-1788.
14. McCarthy HS, Williams JH, Davie MW, Marshall MJ. Platelet-derived growth factor stimulates osteoprotegerin production in osteoblastic cells. J Cell Physiol 2008;218:350-354.
15. Liang L. Estrogen regulates expression of osteoprotegerin and RANKL in human periodontal ligament cells through estrogen receptor beta. J Periodontol 2008;79: 1745-1751.
16. Tezal M, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol 2000;71:1492-1498.
17. Lundstrom A, Jendle J, Stenstrom B, Toss G, Ravald N. Periodontal conditions in 70-year-old women with osteoporosis. Swed Dent J 2001;25:89-96.
18. Österberg T, Lerner UH, Johnell O, Mellström D Relation between previous fracture and loss of teeth independent of bone mineral density: a population study of 567 70-year-old women. J Bone Miner Res 2003;18(Suppl 1): #SU281.
19. Mohammad AR, Hooper DA, Vermilyea SG, Mariotti A, Preshaw PM. An investigation of the relationship between systemic bone density and clinical periodontal status in post-menopausal Asian-American women. Int Dent J 2003;53:121-125.
20. Gur A, Nas K, Kayhan O, Atay MB, Akyuz G, Sindal D. The relation between tooth loss and bone mass in postmenopausal osteoporotic women in Turkey: a multicenter study. J Bone Miner Metab 2003;21:43-47.
21. Takaishi Y, Okamoto Y, Ikeo T. Correlations between periodontitis and loss of mandibular bone in relation to systemic bone changes in postmenopausal Japanese women. Osteoporos Int 2005;16:1875-1882.
22. Nicopoulou-Karayianni K, Tzoutzoukos P, Karayiannis A. Tooth loss and osteoporosis: the osteodent study. J Clin Periodontol 2009;36:190-197.
23. Yoshihara A, Seida Y, Hanada N. The relationship between bone mineral density and the number of remaining teeth in community-dwelling older adults. J Oral Rehabil 2005;32:735-740.
24. Inagaki K, Kurosu Y, Yoshinara N et al. Efficacy of periodontal disease and tooth loss to screen for low bone mineral density in Japanese women. Calcif Tissue Int 2005;77:9-14.
25. Brennan RM, Genco RJ, Hovey KM. Clinical attachment loss, systemic bone density, and gingival calculus in postmenopausal women. J Periodontol 2007; 78:2104-2111.
26. Famili P, Cauley J, Suzuki JB, Weyant R. Longitudinal study of periodontal disease and edentulism with rates of bone loss in older women. J Periodontol 2005;76:11-15.
27. Yoshihara A, Seida Y, Hanada N, Miyazaki H. A longitudinal study of the relationship between periodontal disease and bone mineral density in community dwelling older adults. J Clin Periodontol 2004; 31:680-684.
28. Rodan GA, Martin TJ. Therapeutic approaches to bone disease. Science 2000;289:1508-1514.
29. Taguchi A, Kobayashi J, Suei Y, Ohtsuka M, Tanimoto K, Sanada M. Relationship between estrogen-receptor genotype and tooth loss in postmenopausal women. JAMA 2001;286:2234-2235.
30. Shen EC, Gau CH, Hsieh YD, Chang CY, Fu E. Periodontal status in post-menopausal osteoporosis: a preliminary clinical study in Taiwanese women. J Chin Med Assoc 2004;67:389-393.
31. Jonhson RB, Gilbert JA, Cooper RC et al. Effect of estrogen deficiency on skeletal and alveolar bone density in Sheep. J Periodontol 2002;73:383-391.
32. Ralston SH. Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 2002;87:2460-2466.
33. Sun JL, Meng HX, Cao CF, Tachi Y, Shinohara M, Ueda M. Relationship between vitamin D receptor gene polymorphism and periodontitis. J Periodontal Res 2002;37:263-267.
34. Kiname DF, Hart TC. Genes and gene polymorphisms associated with periodontal disease. Crit rev Oral Biol Med 2003;14:430-449.
35. Taguchi A, Kobayashi J, Suei Y, Ohtsuka M, Nakamoto T, Tanimoto K. Association of estrogen and vitamin D receptor gene polymorphisms with tooth loss and oral bone loss in Japanese postmenopausal women. Menopause 2003;10:250-257.
36. de Brito Junior RB, Scarel-Caminaga RM, Trevilatto PC, de Souza AP, Barros SP. Polymorphisms in the vitamin D receptor gene are associated with periodontal disease. J Periodontol 2004;75: 1090-1095.
37. Zhang L, Meng H, Zhao H, Li Q, Xu L, Chen Z. Estrogen receptor-alpha gene polymorphisms in patients with periodontitis. J Periodontal Res 2004;39:362-366.
38. Suzuki A, Ji G, Numabe Y, Muramatsu M, Gomi K, Kanazashi M. Single nucleotide polymorphisms associated with aggressive periodontitis and severe chronic periodontitis in Japanese. Biochem Biophys Res Commun 2004;317:887-892.
39. Peterlik M, Boonen S, Cross HS, Lamberg-Allardt C. Vitamin D and calcium insufficiency-related chronic diseases: an emerging world-wide public health problem. Int J Environ Res Public Health 2009;6:2585-2607.
40. Hildebolt CF, Pilgram TK, Dotson M, Armamento-Villareal R, Hauser J, Cohen S. Estrogen and/or calcium plus vitamin D increase mandibular bone mass. J Periodontol 2004;75:811-816.
41. Lerner UH. Bone remodeling in post-menopausal osteoporosis. J Dent Res 2006;85:584-595.
42. Mundy GR. Osteoporosis and inflammation. Nutr Rev 2007;1:147-151.
43. Qiming J, Joni AC, Chan HP et al. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol 2007;78:1300-1308.
44. Boch JA, Wara-Aswapati N, Auron PE. Interleukin 1 signal transduction-current concepts and relevance to periodontitis. J Dent Res 2001;80:400-407.
45. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-916.
46. Udagawa N, Kotake S, Kamatani N, Takahashi N, Suda T. The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res 2002;4:281-289.
47. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003;74:391-401.
48. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-361.
49. Meisel P, Heins G, Carlsson LE et al. Dose-effect relation of smoking and the interleukin-1 (IL-1) gene polymorphism in periodontal disease. J Periodontol 2003;1: 197-206.
50. Taguchi A, Sanada M, Suei Y. Effect of estrogen use on tooth retention, oral bone height and oral bone porosity in Japanese postmenopausal women. Menopause 2004; 11:556-562.
51. Park OJ, Shin SY, Choi Y. The association of osteoprotogerin gene polymorphisms with periodontitis. Oral Dis 2008; 14:440-444.
52. Miley DD, Garcia MN, Hildebolt CF. Cross-sectional study of vitamin D and calcium supplementation effects on chronic periodontitis. J Periodontol 2009; 80:1433-1439.
53. Liu D, Xu JK, Figliomeni L, Huang L, Pavlos NJ, Rogers M. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. J Mol Med 2003;11:17-21.
54. Crotti T, Smith MD, Hirsch R, Soukoulis S, Weedon H, Capone M. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003;38:380-387.
55. Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004;83:166-169.
56. Takayanagi H. Inflammatory bone de-struction and osteoimmunology. J Peri-odontal Res 2005;40:287-293.
57. Bezerra MC, Carvalho JF, Prokopowitsch AS, Pereira RM. RANK, RANKL and osteoprotegerin in arthritic bone loss. Braz J Med Biol Res 2005;38:161-170.
58. Lu HK, Chen YL, Chang HC, Li CL, Kuo MY. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodontal Res 2006;41:354-360.
59. Jin Q, Cirelli JA, Park CH et al. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol 2007;78:1300-1308.
60. Geurs MS, Reddy CE. Longitudinal study of bone density and periodontal disease. J Dent Res 2007;86:1110-1114.
61. Duarte PM, Neto JB, Casati MZ, Sallum EA, Nociti FH Jr. Diabetes modulates gene expression in the gingival tissues of patients with chronic periodontitis. Oral Dis 2007;13:594-599.
62. Bostanci N, Ilgenli T, Emingil G et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 2007;34:370-376.
63. Buduneli N, Biyikoǧlu B, Sherrabeh S, Lappin DF. Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients. J Clin Periodontol 2008;35:846-852.
64. Buduneli N, Biyikoǧlu B, Sherrabeh S, Lappin DF. Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment. J Periodontol 2009;80:1274-1280.
65. Tang TH, Fitzsimmons TR, Bartold PM. Effect of smoking on concentrations of receptor activator of nuclear factor kappa B ligand and osteoprotegerin in human gingival crevicular fluid. J Clin Periodontol 2009;36:713-718.
66. Stern A, Laughlin GA, Bergstrom J, Barrett-Connor E. The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor κB legend with bone mineral density in older adults: the Rancho Bernardo Study. Eur J Endocrinol 2007;156:555-562.
67. Chiba Y, Onouchi T, Ikeda T, Adachi J, Tamura Y, Horiuchi T. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women. Gerontology 2009;55:275-280.
68. Nabipour I, Larijani B, Vahdat K et al. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. Menopause 2009;16: 950-955.
69. O'Neill TW, Copper C, Cannata JR. Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: the European Vertebral Osteoporosis Study. Int J Epidemiol 1949; 23:359-565.
70. Glavind L, Attström R. Periodontal self-examination. A motivational tool in periodontics. J Clin Periodontol 1979;6:238-251.
71. Kelly M, Steele J, Nuttal N et al. Adult Health Survey, Oral Health in the United Kingdom. Health. London: The Social Survey Division of the Office for National Statistics, 1989.
72. Gilbert AD, Nuttall NM. Self-reporting of periodontal health status. Brit Dent J 1999; 186:241-244.
73. Joshipura KJ, Pitiphat W, Douglass CW. Validation of self-reported periodontal measures among health professionals. J Public Health Dent 2002;62:115-121.
74. Pitiphat W, Garcia RI, Douglass CW, Joshipura KJ. Validation of self-reported oral health measures. J Public Health Dent 2002;62:122-128.
75. Buhlin K, Gustafsson A, Andersson K, Hakansson J, Klinge B. Validity and limitations of self-reported periodontal health. Community Dent Oral Epidemiol 2002;30: 431-437.
76. Taguchi A, Suei Y, Ohtsuka M. Relationship between self-reported periodontal status and skeletal bone mineral density in Japanese postmenopausal women. Menopause 2005;12:144-148.
77. Nonn L, Peng L, Feldman D, Peeh D. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by Vitamin D. Cancer Res 2006;66:4516-4524.
78. Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm 2008;81:353-373.
79. Anderson PH, Moore AJ, May BK, O'Loughlin PD, Morris HA. Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 2008;23:1789-1797.
80. Shu L, Guan SM, Fu SM, Guo T, Cao M, Ding Y. Estrogen modulates cytokine expression in human periodontal ligament cells. J Dent Res 2008;87:142-147.
81. Taubman MA, Kawai T, Han X. The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies. J Clin Periodontol 2007;34:370-376.